[
  {
    "ts": "2025-12-21T12:31:23+00:00",
    "headline": "Bullish Analyst Sentiment on Fulcrum Therapeutics (FULC) Following Positive Updates from Phase 1b PIONEER Study",
    "summary": "Fulcrum Therapeutics, Inc. (NASDAQ:FULC) is one of the 12 best multibagger stocks to buy heading into 2026. Following encouraging updates from the ongoing Phase 1b PIONEER study evaluating pociredir in sickle cell disease, analyst sentiment around Fulcrum Therapeutics, Inc. (NASDAQ:FULC) appears to be growing. As of December 18, 2025, 80% of analysts are bullish on […]",
    "url": "https://finance.yahoo.com/news/bullish-analyst-sentiment-fulcrum-therapeutics-123123949.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9e9aa5fe-57e5-32bf-9b61-44bc15b05b9d",
      "content": {
        "id": "9e9aa5fe-57e5-32bf-9b61-44bc15b05b9d",
        "contentType": "STORY",
        "title": "Bullish Analyst Sentiment on Fulcrum Therapeutics (FULC) Following Positive Updates from Phase 1b PIONEER Study",
        "description": "",
        "summary": "Fulcrum Therapeutics, Inc. (NASDAQ:FULC) is one of the 12 best multibagger stocks to buy heading into 2026. Following encouraging updates from the ongoing Phase 1b PIONEER study evaluating pociredir in sickle cell disease, analyst sentiment around Fulcrum Therapeutics, Inc. (NASDAQ:FULC) appears to be growing. As of December 18, 2025, 80% of analysts are bullish on […]",
        "pubDate": "2025-12-21T12:31:23Z",
        "displayTime": "2025-12-21T12:31:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/ac222f5096100e036cfe3dc89568ace8",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Bullish Analyst Sentiment on Fulcrum Therapeutics (FULC) Following Positive Updates from Phase 1b PIONEER Study",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LU2FLfKhubXe0kD.EJyMWg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ac222f5096100e036cfe3dc89568ace8.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nSb6YNh4YtBqRwspkeN6dw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/ac222f5096100e036cfe3dc89568ace8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bullish-analyst-sentiment-fulcrum-therapeutics-123123949.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bullish-analyst-sentiment-fulcrum-therapeutics-123123949.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "FULC"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-21T12:31:20+00:00",
    "headline": "High Analyst Confidence on Palvella Therapeutics (PVLA) Following Encouraging Phase 2 Data for QTORIN Rapamycin",
    "summary": "With strong 1-year returns and upside potential, Palvella Therapeutics, Inc. (NASDAQ:PVLA) secures a spot on our list of the 12 best multibagger stocks to buy heading into 2026. On December 16, 2025, analyst confidence in Palvella Therapeutics, Inc. (NASDAQ:PVLA) was seen rising, as the company announced encouraging Phase 2 data for QTORIN rapamycin in cutaneous […]",
    "url": "https://finance.yahoo.com/news/high-analyst-confidence-palvella-therapeutics-123120180.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "94f40c28-761e-3f42-ae01-05fe60454ee9",
      "content": {
        "id": "94f40c28-761e-3f42-ae01-05fe60454ee9",
        "contentType": "STORY",
        "title": "High Analyst Confidence on Palvella Therapeutics (PVLA) Following Encouraging Phase 2 Data for QTORIN Rapamycin",
        "description": "",
        "summary": "With strong 1-year returns and upside potential, Palvella Therapeutics, Inc. (NASDAQ:PVLA) secures a spot on our list of the 12 best multibagger stocks to buy heading into 2026. On December 16, 2025, analyst confidence in Palvella Therapeutics, Inc. (NASDAQ:PVLA) was seen rising, as the company announced encouraging Phase 2 data for QTORIN rapamycin in cutaneous […]",
        "pubDate": "2025-12-21T12:31:20Z",
        "displayTime": "2025-12-21T12:31:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/6a3eb9e1b9760b4bed78b16d1253664c",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "High Analyst Confidence on Palvella Therapeutics (PVLA) Following Encouraging Phase 2 Data for QTORIN Rapamycin",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BmBW9k2APq04bcY0cbi9DA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/6a3eb9e1b9760b4bed78b16d1253664c.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/az9U5V8Z7oN9MQphgaNFnA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/6a3eb9e1b9760b4bed78b16d1253664c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/high-analyst-confidence-palvella-therapeutics-123120180.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/high-analyst-confidence-palvella-therapeutics-123120180.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PVLA"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-21T13:07:57+00:00",
    "headline": "How The Latest Analyst Reset Is Shaping MTN Group’s Long Term Story",
    "summary": "MTN Group’s latest valuation update leaves its fair value estimate and discount rate effectively unchanged, signaling that analysts see no need to rewrite the long term story despite recent market noise. The minimal tweaks to growth assumptions are best read as a technical rebasing rather than a fundamental reset, suggesting the market may already be pricing in a slower, more complex recovery path. Read on to see how these seemingly small adjustments can shape the evolving narrative around...",
    "url": "https://finance.yahoo.com/news/latest-analyst-reset-shaping-mtn-130757108.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "c9ae8a24-37d3-3a2d-b177-39f2b55e2f8e",
      "content": {
        "id": "c9ae8a24-37d3-3a2d-b177-39f2b55e2f8e",
        "contentType": "STORY",
        "title": "How The Latest Analyst Reset Is Shaping MTN Group’s Long Term Story",
        "description": "",
        "summary": "MTN Group’s latest valuation update leaves its fair value estimate and discount rate effectively unchanged, signaling that analysts see no need to rewrite the long term story despite recent market noise. The minimal tweaks to growth assumptions are best read as a technical rebasing rather than a fundamental reset, suggesting the market may already be pricing in a slower, more complex recovery path. Read on to see how these seemingly small adjustments can shape the evolving narrative around...",
        "pubDate": "2025-12-21T13:07:57Z",
        "displayTime": "2025-12-21T13:07:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/6008364ab7a4bfa5cc53e4098a01b3b0",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/54ngJ9HCWnF97pxPsQiK3w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/6008364ab7a4bfa5cc53e4098a01b3b0.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/217hUOMFIAE4nyOrvGlqmA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/6008364ab7a4bfa5cc53e4098a01b3b0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/latest-analyst-reset-shaping-mtn-130757108.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/latest-analyst-reset-shaping-mtn-130757108.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTNOF"
            },
            {
              "symbol": "MTN"
            },
            {
              "symbol": "TFC"
            },
            {
              "symbol": "MT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-21T14:44:23+00:00",
    "headline": "Truist and RBC Capital Raise Price Targets on Intuitive Surgical (ISRG)",
    "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 14 Best Large Cap Stocks to Invest In Now. On December 18, TipRanks reported that Truist increased its price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) from $620 to $650 and maintained its Buy rating on the stock. This update comes as part of a broader research note […]",
    "url": "https://finance.yahoo.com/news/truist-rbc-capital-raise-price-144423037.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "dc61b330-43e9-393d-a069-4d78b8c7b874",
      "content": {
        "id": "dc61b330-43e9-393d-a069-4d78b8c7b874",
        "contentType": "STORY",
        "title": "Truist and RBC Capital Raise Price Targets on Intuitive Surgical (ISRG)",
        "description": "",
        "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 14 Best Large Cap Stocks to Invest In Now. On December 18, TipRanks reported that Truist increased its price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) from $620 to $650 and maintained its Buy rating on the stock. This update comes as part of a broader research note […]",
        "pubDate": "2025-12-21T14:44:23Z",
        "displayTime": "2025-12-21T14:44:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/71b3dca72fccae86d80f11159f2a01a1",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Truist and RBC Capital Raise Price Targets on Intuitive Surgical (ISRG)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/x6StFstItfrANu1rTtytxw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/71b3dca72fccae86d80f11159f2a01a1.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yvL8oIMyuDIj_o5R8h2Xcg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/71b3dca72fccae86d80f11159f2a01a1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/truist-rbc-capital-raise-price-144423037.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/truist-rbc-capital-raise-price-144423037.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TFC"
            },
            {
              "symbol": "ISRG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-21T14:57:27+00:00",
    "headline": "Truist Lifts PT on Broadcom Inc. (AVGO) to $510 From $500",
    "summary": "Broadcom Inc. (NASDAQ:AVGO) is one of the most widely held stocks by hedge funds in 2025. On December 19, Truist lifted the price target on Broadcom Inc. (NASDAQ:AVGO) to $510 from $500 while keeping a Buy rating on the stock. Broadcom Inc. (NASDAQ:AVGO) also received a rating update from Morgan Stanley analyst Joseph Moore on […]",
    "url": "https://finance.yahoo.com/news/truist-lifts-pt-broadcom-inc-145727470.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9f26b4c5-d1a1-3e6a-8c96-a557db7dc976",
      "content": {
        "id": "9f26b4c5-d1a1-3e6a-8c96-a557db7dc976",
        "contentType": "STORY",
        "title": "Truist Lifts PT on Broadcom Inc. (AVGO) to $510 From $500",
        "description": "",
        "summary": "Broadcom Inc. (NASDAQ:AVGO) is one of the most widely held stocks by hedge funds in 2025. On December 19, Truist lifted the price target on Broadcom Inc. (NASDAQ:AVGO) to $510 from $500 while keeping a Buy rating on the stock. Broadcom Inc. (NASDAQ:AVGO) also received a rating update from Morgan Stanley analyst Joseph Moore on […]",
        "pubDate": "2025-12-21T14:57:27Z",
        "displayTime": "2025-12-21T14:57:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4a31470717140dc0b5330d507cacd0ab",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "AVGO Stock: A Strong Buy Pick Backed by Robust Cash Flow and Dividend Growth",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_1PzZo7vqFbaijsBQwbN_A--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4a31470717140dc0b5330d507cacd0ab.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FBSrJzphCNhcjhn0JgD.HA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4a31470717140dc0b5330d507cacd0ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/truist-lifts-pt-broadcom-inc-145727470.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/truist-lifts-pt-broadcom-inc-145727470.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-21T14:57:23+00:00",
    "headline": "Truist Raises PT on NVIDIA Corporation (NVDA) to $275 From $255",
    "summary": "NVIDIA Corporation (NASDAQ:NVDA) is one of the most widely held stocks by hedge funds in 2025. Truist lifted its price target on NVIDIA Corporation (NASDAQ:NVDA) to $275 from $255 on December 19, maintaining a Buy rating on the stock after adjusting price targets in the AI and semiconductor group to take into account its 2027 […]",
    "url": "https://finance.yahoo.com/news/truist-raises-pt-nvidia-corporation-145723577.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "c4fa252b-5b76-327a-b7f0-e11869e825ab",
      "content": {
        "id": "c4fa252b-5b76-327a-b7f0-e11869e825ab",
        "contentType": "STORY",
        "title": "Truist Raises PT on NVIDIA Corporation (NVDA) to $275 From $255",
        "description": "",
        "summary": "NVIDIA Corporation (NASDAQ:NVDA) is one of the most widely held stocks by hedge funds in 2025. Truist lifted its price target on NVIDIA Corporation (NASDAQ:NVDA) to $275 from $255 on December 19, maintaining a Buy rating on the stock after adjusting price targets in the AI and semiconductor group to take into account its 2027 […]",
        "pubDate": "2025-12-21T14:57:23Z",
        "displayTime": "2025-12-21T14:57:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/aa94e059977d3251b8b0630718e013fc",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Analyst Explains How NVIDIA (NVDA) Can Reach $8 Trillion Market Cap",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.ZnJY6aT_ZwW.CJaMIVd5g--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aa94e059977d3251b8b0630718e013fc.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qEoy5Rzsl1ePc1El_kU3KA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/aa94e059977d3251b8b0630718e013fc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/truist-raises-pt-nvidia-corporation-145723577.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/truist-raises-pt-nvidia-corporation-145723577.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-21T14:57:13+00:00",
    "headline": "Truist Slashes PT on Vericel Corporation (VCEL) to $45 From $50",
    "summary": "Vericel Corporation (NASDAQ:VCEL) is one of the best small cap stocks to buy with huge upside potential. Truist analyst Richard Newitter slashed the price target on Vericel Corporation (NASDAQ:VCEL) to $45 from $50 on December 18, reaffirming a Buy rating on the stock as part of a broader research note previewing the coming year for […]",
    "url": "https://finance.yahoo.com/news/truist-slashes-pt-vericel-corporation-145713039.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "b4b06ff7-9aca-3f60-9443-f71525a2a83d",
      "content": {
        "id": "b4b06ff7-9aca-3f60-9443-f71525a2a83d",
        "contentType": "STORY",
        "title": "Truist Slashes PT on Vericel Corporation (VCEL) to $45 From $50",
        "description": "",
        "summary": "Vericel Corporation (NASDAQ:VCEL) is one of the best small cap stocks to buy with huge upside potential. Truist analyst Richard Newitter slashed the price target on Vericel Corporation (NASDAQ:VCEL) to $45 from $50 on December 18, reaffirming a Buy rating on the stock as part of a broader research note previewing the coming year for […]",
        "pubDate": "2025-12-21T14:57:13Z",
        "displayTime": "2025-12-21T14:57:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/e3c3f86e9fe374c2d88328188aef12c5",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Vericel Corporation (VCEL): Among Stocks with Insanely High PE Ratios Insiders Are Selling",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DaVGljWUNPizZcybgQgUFg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/e3c3f86e9fe374c2d88328188aef12c5.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5ivfQSj.T32ktsWIm6XVSQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/e3c3f86e9fe374c2d88328188aef12c5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/truist-slashes-pt-vericel-corporation-145713039.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/truist-slashes-pt-vericel-corporation-145713039.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VCEL"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]